Patents by Inventor Preston A. Marx, JR.

Preston A. Marx, JR. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal antibodies directed against a novel pathogenic west African human immunodeficiency virus type 2 (HIV-2) group F isolate
    Patent number: 9650435
    Abstract: Isolated monoclonal antibodies that bind to HIV-2 isolate NWK08F are provided. In some embodiments, the antibodies bind a polypeptide comprising the HIV-2NWK08F Env, Pol, or Nef proteins, or fragments thereof, respectively. Antigen-binding fragments and humanized versions of the antibody are also provided.
    Type: Grant
    Filed: April 28, 2014
    Date of Patent: May 16, 2017
    Assignee: The Administrators of the Tulane Educational Fund
    Inventors: Stephen M. Smith, Preston A. Marx, Jr.
  • NOVEL HIV-2 ISOLATE
    Publication number: 20140234332
    Abstract: The invention provides a novel strain of HIV-2 capable of causing immunodeficiency. The invention also provides compositions comprising the nucleic acids and polypeptides characteristic of this HIV-2 virus, antibodies specific for this HIV-2 virus, methods of using these compositions, and methods of detecting HIV-2 virus.
    Type: Application
    Filed: April 28, 2014
    Publication date: August 21, 2014
    Applicant: Tulane University Health and Sciences Center
    Inventors: Stephen M. Smith, Preston A. Marx, JR.